This research delves into the application of Deep Learning (DL) to medical imaging for drug discovery, highlighting DL’s ability to enhance diagnostic precision and efficiency. The research looks into the use of DL methods like CNNs and RNNs for automating feature extraction, pattern recognition, and classification in large, complex medical datasets. Effective drug development relies on fast and accurate diagnosis of disease to determine treatment’s therapeutic efficacy and identify therapeutic targets. When applied to huge datasets, DL excels at uncovering subtle patterns and correlations that may be missed by more conventional methods. In addition to improving early disease identification and tailored medicinal therapies, the technology also helps in biomarker discovery. In this study, we discuss some of the obstacles of deploying DL ethically in medical imaging, such as protecting sensitive patient information, ensuring that models can be easily interpreted, and using a wide variety of data. The merger of DL and medical images offers great potential to promote image-based diagnosis in drug discovery, contributing to a more personalized and precise approach in healthcare, ultimately improving patient outcomes and changing the future of modern medicine.